Traditional Chinese medicine composition for treating ovarian reserve function decline disease

Abstract

The invention discloses a traditional Chinese medicine composition for treating an ovarian reserve function decline disease. The traditional Chinese medicine composition is prepared from the following raw materials: rehmannia, rhizoma polygonati, loranthus parasiticus, teasel root, glossy privet fruit, wolfberry fruit, salvia miltiorrhiza, radix curcumae and the like. The traditional Chinese medicine composition has the effects of nourishing kidney and replenishing essence, nourishing blood and soothing liver, and nourishing yin and raising yang, is mainly used for treating kidney essence deficiency and liver depression and blood deficiency, can be used for treating the ovarian reserve function decline disease, and preferably is used for treating ovarian reserve function decline, premature ovarian insufficiency, premature ovarian failure, ovarian hyporeaction, infertility and perimenopausal syndrome caused by the diseases, and the like. Long-term clinical application proves that the traditional Chinese medicine composition is accurate in curative effect, safe and free of a side effect, and has a wide clinical value.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine, and in particular relates to a traditional Chinese medicine composition for treating diseases with decreased ovarian reserve function. Background technique [0002] The ovary is an important female reproductive organ, with two major functions of reproduction and endocrine. The reproductive function includes the recruitment and development of follicles, the maturation and ovulation of follicles, and the formation and degeneration of the corpus luteum. Sex hormones (estrogen, progesterone, androgen), polypeptide hormones and growth factors, etc. Therefore, women's health is inseparable from the normal function of the ovaries. [0003] Ovarian reserve is the medical term for the primordial follicles contained within the cortex of a human female ovary. In women, there is no physiological function to produce primordial follicles. After the baby girl is born, primordial follicles no longer...

AI Technical Summary

Problems solved by technology

The several drugs disclosed in the above two prior art are relatively lacking in the overall regulation of the body, because their treatment methods are different, so patients are required to clarify the luteal phase, menstrual period, follicular phase, and ovulation phase, etc., and for different periods. Disease syndrome and physical syndrome characteristics Take corresponding medicines, so the usage of medicines is complicated, and requires a high level of cognition of patients, it is extremely inconvenient to take, and it is easy for patients to have poor compliance and even the risk of misuse of medicines

[0017] The existing patent technology (publication number CN1134824A) discloses an oral liquid for regulating female sexual function. This invention focuses on the diagnosis and treatment of kidney-yang deficiency, and can be used to improve symptoms such as hyposexuality, vaginal dryness, and listlessness, while ignoring the balance of yin and yang. As well as the coordination of liver, spleen, kidney and other viscera

In addition, the existing patented technology (publication number CN107715074A) discloses a formula of traditional Chinese medicine wine for menopausal syndrome, which has the effect of invigorating qi and blood, and can improve the symptoms of menopausal discomfort, but this invention does not go from the fundamental pathogenesis of the disease Treatment does not achieve the effects of nourishing liver and kidney, regulating blood vessels, etc., and cannot improve and restore ovarian reserve function, and as medicinal wine, it is not suitable for pregnant women who need to take it

Images